Browsing by author "Lord, Sarah J"
Sort by:
Title A-Z
-
The AEDUCATE Collaboration. A Comprehensive antenatal education birth preparation programs to reduce rates of caesarean section in nulliparous women. Protocol for an individual participant data prospective meta-analysis
Levett, Kate M; Lord, Sarah J; Dahlen, Hannah G; Smith, Caroline A; Girosi, Federico; Downe, Soo; Finlayson, Kenneth William; Fleet, Julie; Steen, Mary; Davey, Mary-Ann; Newnham, Elizabeth; Werner, Anette; Arnott, Leslie; Sutcliffe, Kerry; Seidler, Anna Lene; Hunter, Kylie Elizabeth; Askie, LisaPublished 2020Abstract Introduction Rates of medical interventions in normal labour and birth are increasing. This prospective meta-analysis (PMA) proposes to assess whether the addition of a comprehensive multicomponent birth preparation ...Open AccessArticle -
The AEDUCATE Collaboration. Comprehensive antenatal education birth preparation programmes to reduce the rates of caesarean section in nulliparous women. Protocol for an individual participant data prospective meta-analysis
Levett, Kate M; Lord, Sarah J; Dahlen, Hannah G; Smith, Caroline A; Girosi, Federico; Downe, Soo; Finlayson, Kenneth William; Fleet, Julie; Steen, Mary; Davey, Mary-Ann; Newnham, Elizabeth; Werner, Anette; Arnott, Leslie; Sutcliffe, Kerry; Seidler, Anna Lene; Hunter, Kylie Elizabeth; Askie, LisaPublished 2020Introduction Rates of medical interventions in normal labour and birth are increasing. This prospective meta-analysis (PMA) proposes to assess whether the addition of a comprehensive multicomponent birth preparation programme ...Open AccessArticle -
Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib
Lee, Chee Khoon; Goldstein, David; Gibbs, Emma; Joensuu, Heikki; Zalcberg, John; Verweij, Jaap; Casali, Paolo G; Maki, Robert G; Cioffi, Angela; McArthur, Grant; Lord, Sarah J; Yip, Desmond; Kanjanapan, Yada; Rutkowski, PiotrPublished 2015-03-19Purpose Metastatic gastrointestinal stromal tumor (GIST) is generally an incurable disease with variable response to imatinib. We aimed to develop prognostic nomograms to predict overall survival (OS) and progression-free ...Open AccessArticle -
Electronic and animal noses for detecting SARS-CoV-2 infection
Bell, Katy J.L.; Leeflang, Mariska MG; Deeks, Jonathan J; Dinnes, Jacqueline; Doust, Jenny; Korevaar, Daniel A; Lord, Sarah J; Spijker, RenePublished 2021This is a protocol for a Cochrane Review (diagnostic). The objectives are as follows: To assess the diagnostic test accuracy of eNoses to screen for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection ...Open AccessArticle -
Linking the evidence: intermediate outcomes in medical test assessments
Staub, Lukas P; Dyer, Suzanne; Lord, Sarah J; Simes, R JohnPublished 2012-01-01Objectives To review how health technology assessments (HTA) of medical tests incorporate intermediate outcomes in conclusions about the effectiveness of tests on improving health outcomes. Methods Systematic review of ...Open AccessPost-print -
Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001–2016).
Daniels, Benjamin; Kiely, Belinda E; Lord, Sarah J; Houssami, Nehmat; Lu, Christine Y.; Ward, Robyn L.; Pearson, Sallie-AnnePublished 2018Patients treated with trastuzumab for HER2-positive metastatic breast cancer (HER2+MBC) are living longer, but there is little information on their outcomes and treatment experience beyond the median survival from clinical ...Article -
Setting analytical performance specifications using HbA1c as a model measurand
Loh, Tze Ping; Smith, Alison F.; Bell, Katy J.L.; Lord, Sarah J; Ceriotti, Ferruccio; Jones, Graham; Bossuyt, Patrick; Sandberg, Sverre; Horvath, Andrea RPublished 2021Analytical performance specifications (APS) for measurands describe the minimum analytical quality requirements for their measurement. These APS are used to monitor and contain the systematic (trueness/bias) and random ...Article -
Setting minimum clinical performance specifications for tests based on disease prevalence and minimum acceptable positive and negative predictive values: Practical considerations applied to COVID-19 testing
Ping Loh, Tze; Lord, Sarah J; Bell, Katy J.L.; Kathryn Bohn, Mary; Yee Lim, Chun; Markus, Corey; Fares Taie, Hernan; Adeli, Khosrow; Lippi, Giuseppe; Sandberg, Sverre; Horvath, AndreaPublished 2021OBJECTIVES: Several guidelines for the evaluation of laboratory tests for severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection have recommended establishing an a priori definition of minimum clinical ...Open AccessArticle -
Survival outcomes for Australian women receiving trastuzumab for HER2-positive metastatic breast cancer following (neo)adjuvant trastuzumab: a national population-based observational study (2006–2014).
Daniels, Benjamin; Kiely, Belinda E; Houssami, Nehmat; Lord, Sarah J; Dobbins, Timothy; Lu, Christine Y.; Ward, Robyn L.; Pearson, Sallie-AnnePublished 2018Patients treated with (neo)adjuvant trastuzumab who relapse and receive trastuzumab for metastatic breast cancer (MBC) are a growing population with little outcome data given their exclusion from most clinical trials. We ...Open AccessArticle -
Trastuzumab for metastatic breast cancer: Real world outcomes from an Australian whole-of-population cohort (2001–2016).
Daniels, Benjamin; Kiely, Belinda E; Lord, Sarah J; Houssami, Nehmat; Lu, Christine Y.; Ward, Robyn L; Pearson, Sallie-AnnePublished 2018Outcomes for patients treated in clinical trials may not reflect the experience in routine clinical care. We aim to describe the real-world treatment patterns and overall survival (OS) for women receiving trastuzumab for ...Article -
Using patient management as a surrogate for patient health outcomes in diagnostic test evaluation
Staub, Lukas P; Lord, Sarah J; Simes, R John; Dyer, Suzanne; Houssami, Nehmat; Chen, Robert YM; Irwig, LesPublished 2012-01-01Background: Before a new test is introduced in clinical practice, evidence is needed to demonstrate that its use will lead to improvements in patient health outcomes. Studies reporting test accuracy may not be sufficient, ...Open AccessArticle
Sort by:
Title A-Z